New stent grafts tested for aortic repair in european registry

NCT ID NCT07668687

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry is tracking how well two stent grafts, Castor and Cratos, work for treating aortic conditions like dissections and aneurysms. About 100 patients across European hospitals will be followed for up to 5 years. The goal is to see if these devices are safe and effective in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Castor and Cratos branched aortic stent grafts (medical devices)
What this could lead to
If successful, this registry could confirm that these stent grafts are safe and effective for treating serious aortic conditions in everyday practice.
What could go wrong
This is an observational registry, not a controlled trial, so results may be less definitive. Risks include device complications like leaks or migration, and the small size (100 patients) limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM OF AORTA, THORACIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic aneurysm Aortic Intramural Hematoma Dissection, Thoracic Aorta Penetrating Atherosclerotic Ulcer thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ASKLEPIOS Kliniken St. Georg

    RECRUITING

    Hamburg, 20099, Germany

  • Hôpital de Sion

    RECRUITING

    Sion, 1951, Switzerland

  • Universitätsklinikum Münster (UKM)

    RECRUITING

    Münster, 48149, Germany

  • Universitätsspital Zürich (USZ)

    RECRUITING

    Zurich, CH-8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.